Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without having to be on another type of ...

He came up with the idea of putting a very small amount of a derivative of ketamine into a nasal spray device. Husseini Manji: It's like an inhaler except it's delivered to the nose. Basically ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...

Johnson & Johnson's new nasal spray contains the chemical mirror image of ketamine, which has previously been called a "party drug" because of its quasi-psychedelic effects. On Tuesday ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for treatment-resistant depression. No More Pricking: US FDA Approves ...

The remaining 20% is their coinsurance. S-ketamine, or esketamine (Spravato), is an FDA-approved nasal spray that doctors and healthcare professionals may prescribe for major depressive disorder ...

In 2019, the Food and Drug Administration approved esketamine (Spravato), a nasal spray for treatment-resistant depression. Research indicates that ketamine therapy helps individuals who did not ...

We can help. Stella Mental Health in New York specializes in Spravato (esketamine) nasal spray, ketamine infusion therapy, stellate ganglion blocks (SGB) and integration therapy. Schedule an ...

Ketamine therapy is used in the treatment ... LifeStance Health in Oklahoma also provides nasal spray Spravato (esketamine), another therapeutic option for treatment-resistant depression.